Company profile for Avalo Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Avalo is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in areas of significant unmet clinical need. We combine breakthroughs in the understanding of disease pathology and development of novel therapeutics to address underlying disease mechanisms. Our mission is to transform patients’ lives with novel therapeut...
Avalo is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in areas of significant unmet clinical need. We combine breakthroughs in the understanding of disease pathology and development of novel therapeutics to address underlying disease mechanisms. Our mission is to transform patients’ lives with novel therapeutics that realize the promise of first-in-class medicines.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1500 Liberty Ridge Drive Suite 321 Wayne, PA 19087
Telephone
Telephone
610-254-4201
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/17/3189596/0/en/Avalo-Therapeutics-Announces-Inducement-Grants-to-New-Employees-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
17 Nov 2025

https://www.globenewswire.com/news-release/2025/10/29/3176254/0/en/Avalo-Therapeutics-Announces-Completion-of-Enrollment-in-Phase-2-LOTUS-Trial-of-AVTX-009-for-the-Treatment-of-Hidradenitis-Suppurativa.html

GLOBENEWSWIRE
29 Oct 2025

https://www.globenewswire.com/news-release/2025/10/01/3159348/0/en/Avalo-Therapeutics-Expands-Leadership-Team-with-Key-Appointments-in-Business-Development-and-Human-Resources.html

GLOBENEWSWIRE
01 Oct 2025

https://www.globenewswire.com/news-release/2025/09/22/3153766/0/en/Avalo-Therapeutics-Appoints-Kevin-R-Lind-to-Board-of-Directors.html

GLOBENEWSWIRE
22 Sep 2025

https://www.globenewswire.com/news-release/2025/08/27/3139862/0/en/Avalo-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
27 Aug 2025

https://www.globenewswire.com/news-release/2025/08/07/3129053/0/en/Avalo-Reports-Second-Quarter-2025-Financial-Results-and-Recent-Business-Updates.html

GLOBENEWSWIRE
07 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty